Contact this trialFirst, we need to learn more about you.
Chemotherapy
Gemtuzumab + Midostaurin for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Portland, Oregon
This trial is testing a new combination of two drugs, gemtuzumab ozogamicin and midostaurin, to see if it is safe and tolerable in patients with newly diagnosed FLT3-mutated Acute Myeloid Leukemia (AML).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service